Ornithine transcarbamylase deficiency is the most common urea cycle disorder in humans. It is an inherited disorder which causes toxic levels of ammonia to build up in the blood. Ornithine transcarbamylase, the defective enzyme in this disorder, is the final enzyme in the proximal portion of the urea cycle.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Ornithine-Transcarbamylase Deficiency industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
DTX-301
SEL-313
SHP-641
PRX-OTC
Others
Market Segment by Product Application
Hospital
Clinic
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Lucane Pharma SA
PhaseRx Inc
Promethera Biosciences SA
Selecta Biosciences Inc
Translate Bio Inc
Ultragenyx Pharmaceutical Inc
Unicyte AG
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Ornithine-Transcarbamylase Deficiency consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Ornithine-Transcarbamylase Deficiency market by identifying its various subsegments.
3.Focuses on the key global Ornithine-Transcarbamylase Deficiency manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Ornithine-Transcarbamylase Deficiency with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Ornithine-Transcarbamylase Deficiency submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Ornithine-Transcarbamylase Deficiency Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Ornithine-Transcarbamylase Deficiency Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Ornithine-Transcarbamylase Deficiency Segment by Type
2.1.1 DTX-301
2.1.2 SEL-313
2.1.3 SHP-641
2.1.4 PRX-OTC
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Others
2.3 Global Ornithine-Transcarbamylase Deficiency Market Comparison by Regions (2017-2027)
2.3.1 Global Ornithine-Transcarbamylase Deficiency Market Size (2017-2027)
2.3.2 North America Ornithine-Transcarbamylase Deficiency Status and Prospect (2017-2027)
2.3.3 Europe Ornithine-Transcarbamylase Deficiency Status and Prospect (2017-2027)
2.3.4 China Ornithine-Transcarbamylase Deficiency Status and Prospect (2017-2027)
2.3.5 Japan Ornithine-Transcarbamylase Deficiency Status and Prospect (2017-2027)
2.3.6 Southeast Asia Ornithine-Transcarbamylase Deficiency Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Ornithine-Transcarbamylase Deficiency Industry Impact
2.5.1 Ornithine-Transcarbamylase Deficiency Business Impact Assessment - Covid-19
2.5.2 Market Trends and Ornithine-Transcarbamylase Deficiency Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Ornithine-Transcarbamylase Deficiency Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Ornithine-Transcarbamylase Deficiency Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Ornithine-Transcarbamylase Deficiency Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Ornithine-Transcarbamylase Deficiency Manufacturer Market Share
3.5 Top 10 Ornithine-Transcarbamylase Deficiency Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Ornithine-Transcarbamylase Deficiency Market
3.7 Key Manufacturers Ornithine-Transcarbamylase Deficiency Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Ornithine-Transcarbamylase Deficiency Industry Key Manufacturers
4.1 Lucane Pharma SA
4.1.1 Compan Detail
4.1.2 Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.1.3 Lucane Pharma SA 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Lucane Pharma SA News
4.2 PhaseRx Inc
4.2.1 Compan Detail
4.2.2 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.2.3 PhaseRx Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Lucane Pharma SA News
4.3 Promethera Biosciences SA
4.3.1 Compan Detail
4.3.2 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.3.3 Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Promethera Biosciences SA News
4.4 Selecta Biosciences Inc
4.4.1 Compan Detail
4.4.2 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.4.3 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Selecta Biosciences Inc News
4.5 Translate Bio Inc
4.5.1 Compan Detail
4.5.2 Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.5.3 Translate Bio Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Translate Bio Inc News
4.6 Ultragenyx Pharmaceutical Inc
4.6.1 Compan Detail
4.6.2 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.6.3 Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Ultragenyx Pharmaceutical Inc News
4.7 Unicyte AG
4.7.1 Compan Detail
4.7.2 Unicyte AG Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification
4.7.3 Unicyte AG Ornithine-Transcarbamylase Deficiency Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
5 Global Ornithine-Transcarbamylase Deficiency Market Segment by Big Type
5.1 Global Ornithine-Transcarbamylase Deficiency Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Ornithine-Transcarbamylase Deficiency Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Ornithine-Transcarbamylase Deficiency Revenue and Market Share by Big Type (2017-2022)
5.2 DTX-301 Sales Growth Rate and Price
5.2.1 Global DTX-301 Sales Growth Rate (2017-2022)
5.2.2 Global DTX-301 Price (2017-2022)
5.3 SEL-313 Sales Growth Rate and Price
5.3.1 Global SEL-313 Sales Growth Rate (2017-2022)
5.3.2 Global SEL-313 Price (2017-2022)
5.4 SHP-641 Sales Growth Rate and Price
5.4.1 Global SHP-641 Sales Growth Rate (2017-2022)
5.4.2 Global SHP-641 Price (2017-2022)
5.5 PRX-OTC Sales Growth Rate and Price
5.5.1 Global PRX-OTC Sales Growth Rate (2017-2022)
5.5.2 Global PRX-OTC Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Ornithine-Transcarbamylase Deficiency Market Segment by Big Application
6.1 Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Ornithine-Transcarbamylase Deficiency Forecast
7.1 Global Ornithine-Transcarbamylase Deficiency Revenue, Sales and Growth Rate (2022-2027)
7.2 Ornithine-Transcarbamylase Deficiency Market Forecast by Regions (2022-2027)
7.2.1 North America Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
7.2.2 Europe Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
7.2.3 China Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
7.2.4 Japan Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
7.2.5 Southeast Asia Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
7.2.6 Other Regions Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
7.3 Ornithine-Transcarbamylase Deficiency Market Forecast by Type (2022-2027)
7.3.1 Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Type (2022-2027)
7.3.2 Global Ornithine-Transcarbamylase Deficiency Market Share Forecast by Type (2022-2027)
7.4 Ornithine-Transcarbamylase Deficiency Market Forecast by Application (2022-2027)
7.4.1 Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Application (2022-2027)
7.4.2 Global Ornithine-Transcarbamylase Deficiency Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Ornithine-Transcarbamylase Deficiency Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Ornithine-Transcarbamylase Deficiency Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Ornithine-Transcarbamylase Deficiency
Figure Market Concentration Ratio and Market Maturity Analysis of Ornithine-Transcarbamylase Deficiency
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Ornithine-Transcarbamylase Deficiency Market Size by Big Type
Figure Global Market Share of Ornithine-Transcarbamylase Deficiency by Big Type in 2021
Figure DTX-301 Picture (2017-2022)
Figure SEL-313 Picture (2017-2022)
Figure SHP-641 Picture (2017-2022)
Figure PRX-OTC Picture (2017-2022)
Global Ornithine-Transcarbamylase Deficiency Market Size by Big Application
Table Global Ornithine-Transcarbamylase Deficiency Market Size by Application
Figure Global Ornithine-Transcarbamylase Deficiency Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Ornithine-Transcarbamylase Deficiency Comparison by Regions (M USD) (2017-2027)
Figure Global Ornithine-Transcarbamylase Deficiency Market Size (Million US$) (2017-2027)
Figure North America Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate (2017-2027)
Figure China Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Ornithine-Transcarbamylase Deficiency Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Ornithine-Transcarbamylase Deficiency Sales by Manufacturer (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Manufacturer in 2021
Table Global Ornithine-Transcarbamylase Deficiency Revenue by Manufacturer (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Manufacturer in 2021
Table Global Ornithine-Transcarbamylase Deficiency Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Ornithine-Transcarbamylase Deficiency Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Ornithine-Transcarbamylase Deficiency Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Ornithine-Transcarbamylase Deficiency Market
Table Key Manufacturers Ornithine-Transcarbamylase Deficiency Product Type
Table Mergers & Acquisitions Planning
Table Lucane Pharma SA Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of Lucane Pharma SA
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table PhaseRx Inc Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of PhaseRx Inc
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table PhaseRx Inc Recent Development
Table Promethera Biosciences SA Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of Promethera Biosciences SA
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Promethera Biosciences SA Main Business
Table Promethera Biosciences SA Recent Development
Table Selecta Biosciences Inc Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of Selecta Biosciences Inc
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Selecta Biosciences Inc Main Business
Table Selecta Biosciences Inc Recent Development
Table Selecta Biosciences Inc Main Business
Table Selecta Biosciences Inc Recent Development
Table Translate Bio Inc Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of Translate Bio Inc
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Translate Bio Inc Main Business
Table Translate Bio Inc Recent Development
Table Ultragenyx Pharmaceutical Inc Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of Ultragenyx Pharmaceutical Inc
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ultragenyx Pharmaceutical Inc Main Business
Table Ultragenyx Pharmaceutical Inc Recent Development
Table Unicyte AG Company Profile
Table Ornithine-Transcarbamylase Deficiency Product Introduction, Application and Specification of Unicyte AG
Table Ornithine-Transcarbamylase Deficiency Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Unicyte AG Main Business
Table Unicyte AG Recent Development
Figure Global Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Revenue and Growth Rate (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Sales by Regions (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Regions in 2021
Table Global Ornithine-Transcarbamylase Deficiency Revenue by Regions (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Regions in 2021
Figure North America Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Figure Europe Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Figure China Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Figure Japan Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Figure Southeast Asia Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Figure Other Regions Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Sales by Big Type (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Big Type (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Big Type in 2019
Table Global Ornithine-Transcarbamylase Deficiency Revenue by Big Type (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Big Type (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Revenue Market Share by Big Type in 2019
Figure Global DTX-301 Sales Growth Rate (2017-2022)
Figure Global DTX-301 Price (2017-2022)
Figure Global SEL-313 Sales Growth Rate (2017-2022)
Figure Global SEL-313 Price (2017-2022)
Figure Global SHP-641 Sales Growth Rate (2017-2022)
Figure Global SHP-641 Price (2017-2022)
Figure Global PRX-OTC Sales Growth Rate (2017-2022)
Figure Global PRX-OTC Price (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Sales by Big Application (2017-2022)
Table Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Big Application (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Ornithine-Transcarbamylase Deficiency Sales and Growth Rate (2022-2027)
Figure Global Ornithine-Transcarbamylase Deficiency Revenue and Growth Rate (2022-2027)
Table Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Regions (2022-2027)
Table Global Ornithine-Transcarbamylase Deficiency Market Share Forecast by Regions (2022-2027)
Figure North America Sales Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
Figure Europe Sales Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
Figure China Sales Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
Figure Japan Sales Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
Figure Southeast Asia Sales Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
Figure Other Regions Sales Ornithine-Transcarbamylase Deficiency Market Forecast (2022-2027)
Table Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Type (2022-2027)
Table Global Ornithine-Transcarbamylase Deficiency Market Share Forecast by Type (2022-2027)
Table Global Ornithine-Transcarbamylase Deficiency Sales Forecast by Application (2022-2027)
Table Global Ornithine-Transcarbamylase Deficiency Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ornithine-Transcarbamylase Deficiency
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Ornithine-Transcarbamylase Deficiency Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Ornithine-Transcarbamylase Deficiency Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Ornithine-Transcarbamylase Deficiency Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Ornithine-Transcarbamylase Deficiency Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Ornithine-Transcarbamylase Deficiency Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Lucane Pharma SA
PhaseRx Inc
Promethera Biosciences SA
Selecta Biosciences Inc
Translate Bio Inc
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)